HealthSouth Corporation (HLS) Stock Rating Upgraded by Mizuho

HealthSouth Corporation (NYSE:HLS) was upgraded by equities researchers at Mizuho from a “neutral” rating to a “buy” rating in a report released on Thursday. The firm currently has a $55.00 price objective on the stock. Mizuho’s target price points to a potential upside of 14.73% from the company’s previous close.

A number of other brokerages have also recently commented on HLS. Piper Jaffray Companies reiterated a “hold” rating and issued a $50.00 target price on shares of HealthSouth Corporation in a report on Thursday, August 3rd. Zacks Investment Research cut HealthSouth Corporation from a “hold” rating to a “sell” rating in a report on Wednesday, October 4th. Robert W. Baird reiterated a “buy” rating and issued a $55.00 target price on shares of HealthSouth Corporation in a report on Monday, October 9th. ValuEngine cut HealthSouth Corporation from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Finally, Royal Bank Of Canada reissued a “buy” rating and set a $53.00 price target on shares of HealthSouth Corporation in a research note on Wednesday, July 5th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and five have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $51.75.

Shares of HealthSouth Corporation (NYSE:HLS) traded up $2.60 during trading on Thursday, hitting $47.94. The stock had a trading volume of 690,101 shares, compared to its average volume of 897,512. The stock has a market cap of $4,713.03, a PE ratio of 17.18, a price-to-earnings-growth ratio of 1.76 and a beta of 0.52. The company has a current ratio of 1.34, a quick ratio of 1.41 and a debt-to-equity ratio of 1.89. HealthSouth Corporation has a 12-month low of $36.97 and a 12-month high of $49.99.

HealthSouth Corporation (NYSE:HLS) last announced its earnings results on Thursday, October 26th. The company reported $0.66 EPS for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.01. The firm had revenue of $995.60 million during the quarter, compared to analysts’ expectations of $985.75 million. HealthSouth Corporation had a return on equity of 22.81% and a net margin of 6.69%. The company’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.65 EPS. equities analysts expect that HealthSouth Corporation will post 2.72 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This piece was posted by Community Financial News and is owned by of Community Financial News. If you are reading this piece on another site, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this piece can be read at https://www.com-unik.info/2017/11/04/healthsouth-corporation-hls-stock-rating-upgraded-by-mizuho.html.

In other HealthSouth Corporation news, CEO Mark J. Tarr sold 22,625 shares of HealthSouth Corporation stock in a transaction on Monday, August 7th. The stock was sold at an average price of $43.00, for a total transaction of $972,875.00. Following the completion of the sale, the chief executive officer now directly owns 283,134 shares of the company’s stock, valued at approximately $12,174,762. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Yvonne M. Curl bought 1,000 shares of the firm’s stock in a transaction on Wednesday, November 1st. The shares were purchased at an average cost of $45.95 per share, with a total value of $45,950.00. Following the completion of the transaction, the director now owns 64,144 shares in the company, valued at $2,947,416.80. The disclosure for this purchase can be found here. 1.60% of the stock is currently owned by company insiders.

Hedge funds and other institutional investors have recently modified their holdings of the business. First Mercantile Trust Co. raised its position in HealthSouth Corporation by 18.8% during the 2nd quarter. First Mercantile Trust Co. now owns 2,720 shares of the company’s stock valued at $132,000 after purchasing an additional 430 shares in the last quarter. Acrospire Investment Management LLC raised its position in HealthSouth Corporation by 64.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 2,800 shares of the company’s stock valued at $136,000 after purchasing an additional 1,100 shares in the last quarter. Advisor Group Inc. raised its position in HealthSouth Corporation by 33.8% during the 2nd quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock valued at $149,000 after purchasing an additional 781 shares in the last quarter. Petrus Trust Company LTA bought a new stake in HealthSouth Corporation during the 2nd quarter valued at $210,000. Finally, HL Financial Services LLC bought a new stake in HealthSouth Corporation during the 2nd quarter valued at $213,000. 93.11% of the stock is owned by institutional investors and hedge funds.

About HealthSouth Corporation

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Analyst Recommendations for HealthSouth Corporation (NYSE:HLS)

What are top analysts saying about HealthSouth Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for HealthSouth Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit